Hua Liu

Hua Liu

Auto-generated profile, based on publicly available information

Hua Liu

Department of Sports Medicine of the Second Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2017 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
YWYafei Wang
Yafei Wang
DYDongsheng Yu
Dongsheng Yu
ZLZhiming Liu
Zhiming Liu
FZFang Zhou
Fang Zhou
JDJun Dai
Jun Dai
HLHua Liu
Hua Liu
Mesenchymal stem cell therapy for osteoarthritis (OA) has been widely investigated, but the mechanisms are still unclear. Exosomes that serve as carriers of genetic information have been implicated in many diseases and are known to participate in many physiological processes. Here, we investigate the therapeutic potential of exosomes from human embryonic stem cell-induced mesenchymal stem cells (ESC-MSCs) in alleviating osteoarthritis (OA). Exosomes were harvested from conditioned culture media of ESC-MSCs by a sequential centrifugation process. Primary mouse chondrocytes treated with interleukin 1 beta (IL-1β) were used as an in vitro model to evaluate the effects of the conditioned medium with or without exosomes and titrated doses of isolated exosomes for 48 hours, prior to immunocytochemistry or western blot analysis. Destabilization of the medial meniscus (DMM) surgery was performed on the knee joints of C57BL/6 J mice as an OA model. This was followed by intra-articular injection of either ESC-MSCs or their exosomes. Cartilage destruction and matrix degradation were evaluated with histological staining and OARSI scores at the post-surgery 8 weeks. We found that intra-articular injection of ESC-MSCs alleviated cartilage destruction and matrix degradation in the DMM model. Further in vitro studies illustrated that this effect was exerted through ESC-MSC-derived exosomes. These exosomes maintained the chondrocyte phenotype by increasing collagen type II synthesis and decreasing ADAMTS5 expression in the presence of IL-1β. Immunocytochemistry revealed colocalization of the exosomes and collagen type II-positive chondrocytes. Subsequent intra-articular injection of exosomes derived from ESC-MSCs successfully impeded cartilage destruction in the DMM model. The exosomes from ESC-MSCs exert a beneficial therapeutic effect on OA by balancing the synthesis and degradation of chondrocyte extracellular matrix (ECM), which in turn provides a new target for OA drug and drug-delivery system development.

1 May 2015 in Biomaterials
Verified
Journal Article
Closed access
HLHua Liu
Hua Liu
GXGuo Wei Xu
Guo Wei Xu
YWYa Fei Wang
Ya Fei Wang
HZHong Shi Zhao
Hong Shi Zhao
SXSi Xiong
Si Xiong
DXDing Hua Xie
Ding Hua Xie

29 January 2019 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
FSFatemeh Sharifi
Fatemeh Sharifi
SHSu Su Htwe
Su Su Htwe
MRMartina Righi
Martina Righi
HLHua Liu
Hua Liu
APAnna Pietralunga
Anna Pietralunga
Yu Shrike ZhangYu Shrike Zhang
Yu Shrike Zhang

1 May 2019 in iScience
Verified
Journal Article
Open access
YWYafei Wang
Yafei Wang
JHJiayun Huang
Jiayun Huang
LGLin Gong
Lin Gong
DYDongsheng Yu
Dongsheng Yu
CAChenrui An
Chenrui An
HLHua Liu
Hua Liu
A low surface expression level of human leukocyte antigen class I (HLA-I) ensures that the mesenchymal stem cells (MSCs) escape from the allogeneic recipients' immunological surveillance. Here, we discovered that both transcriptional and synthesis levels of HLA-I in MSCs increased continuously after interferon (IFN)-γ treatment, whereas interestingly, their surface HLA-I expression was downregulated after reaching an HLA-I surface expression peak. Microarray data indicated that the post-transcriptional process plays an important role in the downregulation of surface HLA-I. Further studies identified that IFN-γ-treated MSCs accelerated HLA-I endocytosis through a clathrin-independent dynamin-dependent endocytosis pathway. Furthermore, cells that have self-downregulated surface HLA-I expression elicit a weaker immune response than they previously could. Thus uncovering the plasticity of MSCs in the regulation of HLA-I surface expression would reveal insights into the membrane transportation events leading to the maintenance of low surface HLA-I expression, providing more evidence for selecting and optimizing low-immunogenic MSCs to improve the therapeutic efficiency.

1 March 2019 in Applied Materials Today
Verified
Journal Article
Closed access
WWWei Wei
Wei Wei
QZQin Zhang
Qin Zhang
WZWenyan Zhou
Wenyan Zhou
ZLZhiming Liu
Zhiming Liu
YWYafei Wang
Yafei Wang
HLHua Liu
Hua Liu

1 September 2015 in Biomaterials
Verified
Journal Article
Closed access
JWJunjuan Wang
Junjuan Wang
JWJiaqiu Wang
Jiaqiu Wang
PLPing Lu
Ping Lu
YCYouzhi Cai
Youzhi Cai
YWYafei Wang
Yafei Wang
HOHongwei Ouyang
Hongwei Ouyang